{"id":21529,"date":"2023-07-18T08:02:50","date_gmt":"2023-07-18T12:02:50","guid":{"rendered":"https:\/\/medicarereport.org\/?p=21529"},"modified":"2023-07-18T08:02:52","modified_gmt":"2023-07-18T12:02:52","slug":"an-experimental-alzheimers-drug-outperforms-one-just-approved-by-the-fda","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=21529","title":{"rendered":"An experimental Alzheimer&#8217;s drug outperforms one just approved by the FDA"},"content":{"rendered":"\n<p>(By Jon Hamilton for NPR)<\/p>\n\n\n\n<p>Patients in the early stages of Alzheimer&#8217;s may soon have a new option to stave off the loss of memory and thinking.<\/p>\n\n\n\n<p>In a study of more than 1,700 people, the experimental drug donanemab slowed the progression of Alzheimer&#8217;s by about 35%, scientists reported at the Alzheimer&#8217;s Association International Conference in Amsterdam.  Continue reading <a href=\"https:\/\/www.npr.org\/sections\/health-shots\/2023\/07\/17\/1188075646\/donanemab-experimental-alzheimers-drug-outperforms-lecanemab-leqembi\" data-type=\"URL\" data-id=\"https:\/\/www.npr.org\/sections\/health-shots\/2023\/07\/17\/1188075646\/donanemab-experimental-alzheimers-drug-outperforms-lecanemab-leqembi\">here&#8230;<\/a><\/p>\n\n\n\n<p><img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"54\" class=\"wp-image-3902\" style=\"width: 150px;\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/08\/NPR-logo.png\" alt=\"\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/08\/NPR-logo.png 152w, https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/08\/NPR-logo-150x55.png 150w\" sizes=\"auto, (max-width: 150px) 100vw, 150px\" \/><\/p>\n\n\n\n<p class=\"has-small-font-size\"><strong>Notice:<\/strong>&nbsp;The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(By Jon Hamilton for NPR) Patients in the early stages of Alzheimer&#8217;s may soon have a new option to stave<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[26,31,15],"tags":[116,599,76,65,94],"class_list":["post-21529","post","type-post","status-publish","format-standard","hentry","category-alzheimersdementia","category-fda","category-part-dprescription-drugs","tag-alzheimers-disease","tag-donanemab","tag-fda","tag-medicare-part-d","tag-older-adults"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/21529","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=21529"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/21529\/revisions"}],"predecessor-version":[{"id":21530,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/21529\/revisions\/21530"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=21529"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=21529"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=21529"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}